Add BrightSurf on Google Email

Largest diversity study of ‘magic mushrooms’ investigates the evolution of psychoactive psilocybin production

Researchers have sequenced 52 Psilocybe specimens, including 39 species previously unsequenced, to understand the evolution of psychoactive psilocybin production. The study reveals two distinct gene orders within the psilocybin-producing gene cluster, suggesting an ancient split in the genus.

SourceUniversity of Utah·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 9, 2024

New understanding of why kidney cancers become metastatic discovered by MD Anderson researchers

Researchers at MD Anderson Cancer Center have engineered a new model of aggressive renal cell carcinoma, highlighting molecular targets and genomic events that trigger chromosomal instability. The loss of interferon receptor genes plays a pivotal role in allowing cancer cells to become tolerant of chromosomal instability.

Researchers discover new class of ribosomal peptide with hemolytic activity

Researchers at the University of Illinois have identified a novel class of ribosomal peptides called daptides, which exhibit hemolytic activity. This discovery opens up new avenues for therapeutic development and highlights the vast potential of undiscovered RiPP classes.

SourceCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign·JournalNature Communications·TypeExperimental study·DateApr 4, 2023

Gene cluster reshuffling drives natural sunscreen evolution in lichens

Lichen-forming fungi have evolved unique gene clusters to produce orange 'sunscreen' pigments, allowing them to thrive in sunny environments. The discovery of a critical ABC transporter gene within the pigment gene cluster provides a potential hypothesis for toxicity avoidance in these organisms.

SourceSMBE Journals (Molecular Biology and Evolution and Genome Biology and Evolution)·JournalGenome Biology and Evolution·TypeExperimental study·DateFeb 9, 2023

Rice University scientists get fungi to spill their secrets

Researchers at Rice University have developed a multiplex base-editing platform that significantly improves the pace of new drug discovery by inducing fungi to produce more bioactive compounds. The technique has been deployed as a tool for mining fungal genomes for medically useful compounds, reducing research timeline by over 80%.

SourceRice University·JournalJournal of the American Chemical Society·TypeExperimental study·DateJan 6, 2023

Revealing biochemical “rings of power”

Researchers at Max-Planck Institute for Terrestrial Microbiology have deciphered the biosynthesis of benzobactins, a class of natural compounds with special biological activity. The study reveals that these compounds are widespread in diverse bacteria and could be excellent candidates for future drug therapy.

SourceMax-Planck-Gesellschaft·JournalAngewandte Chemie·TypeMeta-analysis·DateNov 18, 2022

Collaborative team at IGB discovers new natural products at unprecedented speed

A collaborative team at IGB discovered 30 new compounds, including three with antibacterial properties, using the Illinois Biological Foundry for Advanced Biomanufacturing. The platform allowed for rapid screening of hundreds of genes and pathways, enabling the researchers to identify potential anti-microbial compounds.

SourceCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign·JournalNature Communications·TypeExperimental study·DateOct 18, 2022

Hidden genes may be tapped for new antibiotics

Rice University bioscientists have developed a novel approach to control the expression of 'silent' genes in bacteria using CRISPR technology. This strategy could lead to the discovery of new antibiotics and has potential applications in antifungal and anticancer agents, as well as agriculture.

SourceRice University·JournalNucleic Acids Research·TypeExperimental study·DateJul 11, 2022

How to find marker genes in cell clusters

A new statistical method called Association Plot facilitates the determination and analysis of marker genes in single-cell data. This allows researchers to trace back RNA molecules to their cell of origin, providing insights into cell-type specific genes.

SourceMax-Planck-Gesellschaft·JournalJournal of Molecular Biology·TypeData/statistical analysis·DateJul 6, 2022

Oncotarget | A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis

A recent study identified 34 novel genes that contribute to endocrine resistance in breast cancer using dynamic gene expression analysis. The researchers found that these genes are differentially expressed in both estrogen receptor-positive and triple-negative breast cancers, suggesting shared genetic mechanisms underlying resistance d...

SourceImpact Journals LLC·JournalOncotarget·TypeComputational simulation/modeling·DateJun 8, 2022

Finding new weapons in nature's battlesites

A research team from the Max Planck Institute for Terrestrial Microbiology has identified 1,000 biosynthetic gene clusters, over half of which are previously unknown. These natural products have been found to be eukaryotic proteasome inhibitors that suppress the immune system of insects, as well as other virulence factors.

SourceMax-Planck-Gesellschaft·JournalNature Chemistry·DateApr 28, 2022

The hidden talent of fungi

Researchers at TU Wien propose a new method to interpret and mine fungal genomes to predict essential genes for the production of valuable substances. The FunOrder method identifies co-evolved genes that are functionally necessary, distinguishing them from gap genes.

SourceVienna University of Technology·JournalPLOS Computational Biology·TypeData/statistical analysis·DateOct 4, 2021

When stubborn bugs refuse to make drugs

Researchers at Washington University in St. Louis used comparative metabologenomics to study the genomes of Streptomyces bacteria and identify key factors that influence drug production. The study found that fine-tuning of specific nucleotides can control antibiotic production, offering new insights for next-generation drug discovery.

SourceWashington University in St. Louis·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJul 29, 2021

Winning gene combination takes all

Scientists have successfully identified the complete avenacin biosynthetic pathway in oats, which provides resistance to soil-borne diseases like take-all. This discovery has implications for creating disease-resistant lines of wheat using modern technologies.

SourceJohn Innes Centre·JournalNature Communications·DateMay 7, 2021

Genome mining reveals novel production pathway for promising malaria treatment

Researchers at the University of Illinois have discovered a new biochemical trick used by microbes to produce an antimicrobial compound effective against malaria. The discovery reveals a completely unknown production pathway, which may lead to the development of more efficient and cost-effective methods for producing similar compounds.

Unmuting large silent genes lets bacteria produce new molecules, potential drug candidates

Scientists at the University of Illinois have developed a technique to activate large silent gene clusters in Streptomyces bacteria, yielding new natural products and potential anti-microbial drugs. By using transcription factor decoys, researchers successfully expressed genes that had previously remained dormant.

Scientists discover master switch to turn on silent biosynthetic gene clusters

Researchers at Princeton University have discovered a master switch that 'switches on' silent biosynthetic gene clusters in bacteria, leading to the production of new compounds with anti-parasitic properties. The global regulator, scmR, acts as a gatekeeper for expression and can be eliminated genetically to release molecules of interest.

SourcePrinceton University·JournalProceedings of the National Academy of Sciences·DateApr 13, 2017

New tool, RODEO, promises to capture the breadth of microbial biosynthetic potential

Researchers developed software RODEO to identify clusters of genes indicating an organism's ability to synthesize therapeutically promising molecules. The tool uses machine learning approach to recognize predictive genomic features and has been successfully applied to a class of molecules called lasso peptides.

A novel roadmap through bacterial genomes leads the way to new drug discovery

Researchers at the University of Illinois have developed a database that analyzes microbial genomic data to speed up the discovery of new therapeutic drugs. The database allows scientists to identify promising gene clusters and predict the production of natural products, enabling them to target specific bacterial strains for study.

New method of DNA editing allows synthetic biologists to unlock secrets of a bacterial genome

Researchers have developed a novel DNA engineering technique to discover potentially valuable functions hidden within bacterial genomes. By reprogramming gene expression, they were able to increase the production of previously unknown compounds with useful biomedical applications.

The swing of architect genes

Scientists demonstrate the existence of two distinct regulatory domains controlling arm and hand formation, revealing a complex genetic switch that enables wrist emergence. The study sheds light on the molecular processes governing limb development, highlighting the intricate dialogue between genes and regulatory elements.

SourceUniversité de Genève·JournalScience·DateJun 6, 2013

Mining the botulinum genome

Researchers analyzed the genome of C. botulinum bacteria to understand how they acquired their deadly neurotoxin gene cluster. The study found that the bacteria picked up the cluster in a single event and discovered fragments of other toxin genes, suggesting a 'hotspot' for gene transfer.

SourceNorwich BioScience Institutes·JournalGenome Biology and Evolution·DateMay 14, 2013